Generation Bio (GBIO) - הון עצמי של החברה
Generation Bio Co. (GBIO) leads the development of cell-free gene delivery systems, granting the company significant pricing power over its therapies. However, a lack of profitability and the costs associated with manufacturing plants create serious financial challenges. The current metric stands at 0.05. Market price action on GURU.Markets reflects the risk of secondary offerings and potential failures in early-stage testing of new platforms.
פילוחים אנליטיים של חברת Generation Bio Corp (GBIO)
Book value reflects the value of net assets, representing the difference between all assets and liabilities to assess the internal stability of the business. By analyzing the book value of Generation Bio Co. (GBIO), an investor sees the financial foundation supporting the implementation of eco-friendly synthesis methods and strict bioethical standards, confirming the issuer's ability to develop safe genetic technologies without critical dependence on external borrowing.